This rebrand completes a successful two-year integration of Magellan Rx Management (MRx) into our organization. In keeping with the commitment made by Prime Therapeutics (Prime) in connection with the MRx transaction, we will no longer use the MRx name after Dec. 2.

These resources help clients and vendors understand the strategic shifts we are making as an organization, how these shifts influence our identity evolution and how to confidently implement the new Prime brand.